Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor-related orphan receptor gamma t (RORγt) is a nuclear hormone receptor and transcription factor, encoded as an isoform of the RORC gene. It is a master regulator in the development and function of T helper 17 (Th17) cells, which are critical for immune responses and play key roles in autoimmune diseases. RORγt acts as a DNA-binding transcription factor, and upon ligand binding to its ligand-binding domain (LBD), undergoes conformational changes that allow recruitment of coactivators or corepressors, thereby regulating the expression of target genes. Small molecule modulators targeting the LBD have been developed for therapeutic purposes.
Ligand-dependent DNA-binding transcription factor recruiting coactivators or corepressors to regulate gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor-related orphan receptor gamma t (RORγt).